Mutations in CHD7 and in the MLL3/4 complex are frequently found in medulloblastoma, and MLL3/4 is also found inactivated in many additional cancers (Ford and Dingwall, 2015, Robinson et al., 2012). This evidence concerns the gene KMT2C and medulloblastoma.